EURAX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Eurax, and when can generic versions of Eurax launch?
Eurax is a drug marketed by Journey and is included in two NDAs.
The generic ingredient in EURAX is crotamiton. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the crotamiton profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for EURAX?
- What are the global sales for EURAX?
- What is Average Wholesale Price for EURAX?
Summary for EURAX
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Drug Prices: | Drug price information for EURAX |
| What excipients (inactive ingredients) are in EURAX? | EURAX excipients list |
| DailyMed Link: | EURAX at DailyMed |
US Patents and Regulatory Information for EURAX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Journey | EURAX | crotamiton | CREAM;TOPICAL | 006927-001 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Journey | EURAX | crotamiton | LOTION;TOPICAL | 009112-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
